Annual report pursuant to Section 13 and 15(d)

Segment Reporting (Tables)

v3.25.0.1
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Summary of Operating Costs and Expenses and Interest Expense, Net

 

Years Ended December 31,

 

 

2024

 

 

2023

 

 

2022

 

Segment cost of sales (a)

$

 

 

$

 

 

$

 

Segment research and development (b) (c) (d)

 

(10,247

)

 

 

(37,842

)

 

 

(14,456

)

Segment general and administration (c) (d)

 

(7,789

)

 

 

(7,092

)

 

 

(9,369

)

Share-based compensation expense (see Note 14)

 

(376

)

 

 

(784

)

 

 

(4,758

)

Depreciation and amortization

 

(284

)

 

 

(1,750

)

 

 

(1,800

)

Operating loss

$

(18,696

)

 

$

(47,468

)

 

$

(30,383

)

a)
Amortization expense of $254 related to the Pfizer Intangible asset has been excluded for the year ended December 31, 2024 and included within depreciation and amortization.
b)
Amortization expense of $1,719 and $1,716 related to the ACSD intangible asset has been excluded for the years ended December 31, 2023 and 2022, respectively, and included within depreciation and amortization.
c)
Share-based payment expense of $193, $412 and $1,396 related to research and development and $170, $372 and $3,362 related to general and administration have been excluded for the years ended December 31, 2024, 2023 and 2022, respectively, and included within share-based compensation expense.
d)
Depreciation expense of $18, $19 and $49 related to research and development and $12, $12 and $35 related to general and administration have been excluded for the years ended December 31, 2024, 2023 and 2022, respectively, and included within depreciation and amortization.

Interest Expense, Net

 

Years Ended December 31,

 

 

2024

 

 

2023

 

 

2022

 

Interest income

$

789

 

 

$

1,722

 

 

$

819

 

Interest expense

 

(3,311

)

 

 

(3,150

)

 

 

(3,180

)

Interest expense, net

$

(2,522

)

 

$

(1,428

)

 

$

(2,361

)

Schedule of Distribution of Long-lived Assets by Geographical Area

The distribution of long-lived assets by geographical area was as follows:

Long lived assets

 

December 31, 2024

 

 

December 31, 2023

 

Ireland

 

$

19,759

 

 

$

342

 

U.S.

 

 

15

 

 

 

287

 

Total

 

$

19,774

 

 

$

629